# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-24-001881
Filing Date
2024-05-29
Accepted
2024-05-29 16:01:12
Documents
5
Period of Report
2024-05-29

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 6-K | zk2431527.htm | 6-K | 13041
2 | EXHIBIT 99.1 | exhibit_99-1.htm | EX-99.1 | 215087
3 | EXHIBIT 99.2 | exhibit_99-2.htm | EX-99.2 | 25084
4 |  | image0.jpg | GRAPHIC | 516429
5 |  | image2.jpg | GRAPHIC | 33267
| Complete submission text file | 0001178913-24-001881.txt |  | 1011271

Mailing Address 42 HAYARKON STREET YAVNE L3 8122745
Business Address 42 HAYARKON STREET YAVNE L3 8122745 97289324010
MediWound Ltd. (Filer) CIK: 0001593984 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36349 | Film No.: 24998223
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)